Pharmaceuticals and Biotech

Upcoming Conferences

Sort By Date
Date Jun 20 - 21, 2012
Location London
Patent lifecycle management is becoming more crucial for pharmaceutical companies with the cost of research and drugs continually rising and companies constantly trying to obtain the maximum financial benefit from existing patent terms. In addition to protecting existing IP rights and seeking methods to extend current patent lifecycles, pharmaceutical companies are faced with the challenge of inventing new drugs and diversifying portfolios to replace sales on older and generic drugs.
Date Sep 25 - 26, 2012
Location Brussels
Don’t miss this outstanding opportunity to learn from and network with those at the forefront of pharma regulatory law in the EU Market. Confi rm your participation today and be rewarded with a signifi cant discount.
Date Oct 10 - 11, 2012
Location London
C5’s 23rd Forum on Biotech & Pharmaceuticals Patenting brings together experienced in-house counsel from both innovator and generic pharma and biotech companies and their expert legal advisors from various jurisdictions across the globe. Based on their personal experience, the expert panel will lead you through invaluable, practical, and in-depth sessions.

LinkedIn Testimonials

  • Bjørn von Ryberg
    Bjørn von Ryberg, Partner at ABSALON Advokatfirma

    Copenhagen Area, Denmark

    I have chaired and/or participated in several C5 conferences. It is my experience that they are the best on the market when it comes to high level presentations on intellectual property and regulatory issues.
    • March 15, 2012
  • Stratmann Klemens
    Stratmann Klemens, Unternehmensinhaber - Partner at Hoffmann Eitle Patent- und Rechtsanwälte

    Munich Area, Germany

    very useful conference series with comprehensive high quality presentations, an excellent opportunity for networking, important legal update for my daily practice
    • March 6, 2012
  • ,

    great opportunity to meet and share experiences and views with all stakeholders relevant for pharma patent litigation including judges, litigation lawyers, originators, generics
    • March 2, 2012
  • Nick Bassil
    Nick Bassil, Owner at Kilburn & Strode

    London, United Kingdom

    Tremendously useful conference series, with detailed legal updates and great opportunities for networking.
    • March 1, 2012
  • Karolyn Fletcher
    Karolyn Fletcher, Legal Director at Bristol-Myers Squibb

    Southall, United Kingdom

    One of the best specialised conferences for the pharma industry, with some excellent speakers (e.g. Feb 2012 - Adela Willaims, Victoria Kitcatt) who give very clear, concise and pragmatic advice, rather than purely theoretical updates. Given the quality of the delegates as well as the speakers, the networking opportunities are usually good too.
    • March 1, 2012
  • Catherine Longeval
    Catherine Longeval, Independent Law Practice Professional

    Brussels Area, Belgium

    I found the program of last year's European Pharma Regulatory Law Conference in Brussels (on Sept 22nd, 2012) very comprehensive and enjoyed meeting other industry experts on that occasion.
    • February 29, 2012
  • Petr Kusy
    Petr Kusy, Attorney at Čermák a spol.

    Prague, The Capital, Czech Republic

    I recommend this product
    • February 29, 2012
  • Clare Dunne
    Clare Dunne, Manager, Patent Focus at IMS Health

    London, United Kingdom

    Well-organized conferences with interesting talks and a good opportunity to meet experts in their fields
    • February 29, 2012
  • Phil Carey
    Phil Carey, Senior Associate Solicitor, Intellectual Property (Patent Litigation) at Winston & Strawn

    London, United Kingdom

    I recently attended the C5 Pharma/Biotech conferences in Amsterdam (Patent Litigation) and London (EU Law and Regulation). A good variety of subject matter means an education for all attendees. Having spoken/chaired at both meetings, I can also vouch for the professional and friendly approach from the organisers at C5.
    • February 29, 2012
  • Julian Hitchcock
    Julian Hitchcock, Director at CellFate

    United Kingdom

    I echo the remarks made by colleagues. A very high standard indeed; well focused and authoritative.
    • September 20, 2011
  • Iain Armstrong
    Iain Armstrong, Patent Director at Harrison Goddard Foote

    Manchester, United Kingdom

    C5 produces well thought out conferences with speakers from a range of backgrounds providing useful information from a number of different perspectives. The conferences are well attended, and provide an excellent chance to network with both delegates and speakers.
    • August 3, 2011
  • Sally Shorthose
    Sally Shorthose, Partner at Bird & Bird (law firm)

    London, United Kingdom

    Always well organised and with "clout" to attract high quality speakers and delegated. They go to great lengths to ensure presentations are relevant, of interst and up to date.
    • April 1, 2011
  • Rob Fitt
    Rob Fitt, Senior Associate at Bristows

    United Kingdom

    Very well attended conferences with high quality presentations from impressive panels of speakers.
    • March 15, 2011
  • Kristina Cornish
    Kristina Cornish, Owner at Kilburn & Strode

    United Kingdom

    These conferences provide an excellent combination of education and networking. They are truly "international". I recommend attending.
    • February 28, 2011
  • Anna Dibell
    Anna Dibell, ICC Coach & Business Consultant at Purpureus

    Malmö Area, Sweden

    I attended the eCTD Summit in September 2010. A great way to keep updated and to share knowledge and experience with colleagues and key players from both industry and authorities.
    • February 24, 2011
  • Cyra Nargolwalla
    Cyra Nargolwalla, Owner at Cabinet Plasseraud

    Paris Area, France

    I have always enjoyed attending and speaking at C5 IP conferences for a number of reasons: the organization is impeccable, the topics are timely and relevant, the speakers and attendees hail from a wide variety of backgrounds and so have much to share. All in all, a very successful mix!
    • February 24, 2011
  • Eric Steffe
    Eric Steffe, Director at Sterne, Kessler, Goldstein & Fox

    Washington D.C. Metro Area

    The C5 Pharma/BioPharma IP conferences are worth the time committment. They provide an international perspective to a rapidly evolving field where IP is of paramount importance.
    • February 23, 2011
  • David Resnick
    David Resnick, Co-Leader, Patent Group/Leader, Biotechnology/Chemistry Team, Partner at Nixon Peabody LLP

    Greater Boston Area

    I attended two C5 Biotech conferences. Both conferences were excellent. I came away with a better understanding of issues unique to the European patent system. I also met a number of friends and business contacts, several of which I now work with on a regular basis.
    • February 18, 2011
  • Marianne Schaffner
    Marianne Schaffner, Partner at Linklaters

    Paris Area, France

    Very well organised conferences as a speaker and as an attendee. C5 focuses on strategic topics with the aim of meeting the pharma business needs. The pragmatic approach has to be underlined.
    • February 17, 2011
  • ,

    The conference was informative, but it also demonstrated the knack of making an event conducive to quality interactions.
    • January 24, 2011
  • Alain Seront
    Alain Seront, Manager of the Document Management and Publishing Team at GlaxoSmithKline Biologicals

    Charleroi Area, Belgium

    I attended the "Successful Lifecycle Management of the eCTD" C5 Conference: key players in the industry were presents and provided valuable information about the last updates in the field of electronic submissions, and a good view of what the future will look like.
    • January 24, 2011
  • Mark Einerhand
    Mark Einerhand, European Patent Attorney, Partner at Vereenigde

    Utrecht Area, Netherlands

    The C5s Biotech Patenting Conferences are for me the best way to get updated on the latest developments in the Biotech IP field. The presentations cover a lot of ground but are also concise and to the point. They provide the necessary background and the hands-on information that can be applied immediately in every day practice.
    • January 24, 2011
  • Rana Gosain
    Rana Gosain, Partner at Daniel Advogados

    Brazil

    Well-organized, informative conference; speakers with diverse viewpoints and perspectives; good opportunities for networking with attendees from various backgrounds"
    • January 24, 2011

Featured Conferences

Twitter

Latest C5 Blog Posts

Pharmaceuticals and Biotech

Employment Opportunities

Pharmaceuticals and Biotech

Biotech/generalist attorney
Law Firm • Full-Time
Manchester •
European Patent Attorney
Pharmaceutical • Full-Time
London •